« Back
Home /
ATG4D Antibody

ATG4D Antibody

Item no.	BM-CAF14859-100ug
Manufacturer	Biomatik
Amount	100ug
Category	Antibodies Cell Biology Cell Status Immunohistochemistry Western Blot ELISA Immunofluorescence Immunocytochemistry Autophagy Primary Antibodies
Type	Antibody Polyclonal
Applications	WB, IF, IHC, ICC, ELISA
Specific against	Human, Mouse
Host	Rabbit
Isotype	IgG
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Available
Immunogen	A synthesized peptide
Conjugation	Unconjugated
Specificity	ATG4D Antibody detects endogenous levels of total ATG4D
Gene ID	84971
Gene Name	ATG4D
Swiss-Prot	Q86TL0
Purification	The antiserum was purified by peptide affinity chromatography.
Concentration	1mg/ml
Storage	-20C
Expiry Date	1 year
Shipping Condition	Ice packs
Comments	Cysteine protease ATG4D: Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms.
Technical Notes	WB 1:500ca.1:1000 IHC: 1:50ca.1:200, IF/ICC: 1:100-1:500
Restriction	For Research Use Only. Not for use in diagnostic procedures, drug use, or for administration to humans or animals.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100ug

available

Delivery expected until 8/30/2024